Literature DB >> 33539479

Polycystic ovary syndrome and extremely preterm birth: A nationwide register-based study.

Heiddis Valgeirsdottir1, Inger Sundström Poromaa1, Theodora Kunovac Kallak1, Eszter Vanky2,3, Tansim Akhter1, Nathalie Roos4, Olof Stephansson4,5, Anna-Karin Wikström1,4.   

Abstract

INTRODUCTION: Women with polycystic ovary syndrome (PCOS) have increased risk of pregnancy complications, including preterm birth before 37 weeks. However, if this increased risk also includes extremely preterm births (<28 weeks) is unknown. Such information is important to identify women at risk and tailor antenatal care, since child morbidity and mortality become more prevalent with increasing prematurity. AIMS: To investigate the association between PCOS and extremely preterm birth, and whether onset of PCOS-related preterm birth is predominantly spontaneous or medically indicated.
MATERIAL AND METHODS: This was a nationwide register-based cohort study in Sweden. The study population was all live singleton births registered in the Swedish Medical Birth Register 2005-2014 (n = 1 046 448). Women with and without PCOS were compared by severity of preterm birth [extremely (22+0 to 27+6 weeks), very (28+0 to 31+6 weeks) and moderately (32+0 to 36+6 weeks)] and delivery onset mode (spontaneous or medically indicated). Multinomial logistic regression was performed to estimate adjusted odds ratios (aOR) with 95% confidence intervals (CI). Adjustments were made for maternal age, parity, body mass index, smoking, country of birth and year of delivery.
RESULTS: During the study period, 1.3% of the women giving birth had PCOS diagnosis. They had an overall higher preterm birth rate than women without PCOS (6.7% and 4.8%, respectively). Women with PCOS had increased odds of preterm birth of all severities, with the highest odds for extremely preterm birth (aOR 2.3; 95% CI 1.7-3.0), particularly of spontaneous onset (aOR 2.7; 95% CI 2.0-3.6).
CONCLUSIONS: Women with PCOS had more than a two-fold increased risk of extremely preterm birth with spontaneous onset than women without such diagnosis. This can be important in antenatal risk assessment of preterm birth in women with PCOS. Future research is warranted to investigate the biological mechanisms behind preterm birth in women with PCOS.

Entities:  

Mesh:

Year:  2021        PMID: 33539479      PMCID: PMC7861420          DOI: 10.1371/journal.pone.0246743

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  34 in total

1.  Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization.

Authors:  Lynn Sterling; Jennifer Liu; Nan Okun; Anamika Sakhuja; Sony Sierra; Ellen Greenblatt
Journal:  Fertil Steril       Date:  2015-12-02       Impact factor: 7.329

2.  Is PCOS an inflammatory process?

Authors:  Antoni J Duleba; Anuja Dokras
Journal:  Fertil Steril       Date:  2012-01       Impact factor: 7.329

3.  Pregnancy and perinatal outcomes in women with polycystic ovary syndrome and twin births: a population-based cohort study.

Authors:  T S Løvvik; A-K Wikström; M Neovius; O Stephansson; N Roos; E Vanky
Journal:  BJOG       Date:  2015-03-11       Impact factor: 6.531

4.  Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes.

Authors:  Stefano Palomba; Angela Falbo; Tiziana Russo; Achille Tolino; Francesco Orio; Fulvio Zullo
Journal:  Fertil Steril       Date:  2009-12-11       Impact factor: 7.329

Review 5.  The epidemiology, etiology, and costs of preterm birth.

Authors:  Heather A Frey; Mark A Klebanoff
Journal:  Semin Fetal Neonatal Med       Date:  2016-01-11       Impact factor: 3.926

6.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

7.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

8.  Preterm birth and mortality and morbidity: a population-based quasi-experimental study.

Authors:  Brian M D'Onofrio; Quetzal A Class; Martin E Rickert; Henrik Larsson; Niklas Långström; Paul Lichtenstein
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

Review 9.  Polycystic ovary syndrome and metabolic syndrome.

Authors:  Aus Tariq Ali
Journal:  Ceska Gynekol       Date:  2015-08

Review 10.  Cross-Country Individual Participant Analysis of 4.1 Million Singleton Births in 5 Countries with Very High Human Development Index Confirms Known Associations but Provides No Biologic Explanation for 2/3 of All Preterm Births.

Authors:  David M Ferrero; Jim Larson; Bo Jacobsson; Gian Carlo Di Renzo; Jane E Norman; James N Martin; Mary D'Alton; Ernesto Castelazo; Chris P Howson; Verena Sengpiel; Matteo Bottai; Jonathan A Mayo; Gary M Shaw; Ivan Verdenik; Nataša Tul; Petr Velebil; Sarah Cairns-Smith; Hamid Rushwan; Sabaratnam Arulkumaran; Jennifer L Howse; Joe Leigh Simpson
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

View more
  2 in total

1.  Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.

Authors:  Xinxia Chen; Mika Gissler; Catharina Lavebratt
Journal:  Hum Reprod       Date:  2022-05-30       Impact factor: 6.353

2.  Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England.

Authors:  Anuradhaa Subramanian; Siang Ing Lee; Katherine Phillips; Konstantinos A Toulis; Punith Kempegowda; Michael W O'Reilly; Nicola J Adderley; Shakila Thangaratinam; Wiebke Arlt; Krishnarajah Nirantharakumar
Journal:  BMC Med       Date:  2022-08-30       Impact factor: 11.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.